Market News AIOpen the app

ACAD stock news · ACADIA PHARMACEUTICALS INC

Stories about ACADIA PHARMACEUTICALS INC (ACAD) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ACAD

Follow ACADIA PHARMACEUTICALS INC (ACAD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ACAD
Free on the App Store and Google Play, or on the web.
  1. Sep 24, 2026, 5:15 PM ET · Market

    ACADIA PHARMACEUTICALS INC shared important news about its Alzheimer's drug trial results.

    Neutral

    ACAD reported Phase 2 topline: the main endpoint narrowly missed significance (p=0.0603), a secondary was nominally significant, and the company will continue Phase 3 with protocol changes.

  2. Sep 24, 2026, 12:18 PM ET · Results

    Crude oil prices go up more than 4%, while Darden's earnings fall short of what people expected.

    Bad for ACAD

    ACADIA shares fell after disclosing Phase 3 enabling topline results that the market interpreted negatively for the drug program.

  3. Sep 11, 2026, 6:32 PM ET · Rules

    Acadia Pharmaceuticals got early court approval for a deal about a stockholder lawsuit.

    Neutral

    Acadia reported a court's preliminary approval of a shareholder-derivative settlement; the filing clarifies the case but reveals no payment details, so it leaves the company view unchanged.